MAMEX

K992037 · Del Medical Imaging Corp. · IZH · Jul 30, 1999 · Radiology

Device Facts

Record IDK992037
Device NameMAMEX
ApplicantDel Medical Imaging Corp.
Product CodeIZH · Radiology
Decision DateJul 30, 1999
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 892.1710
Device ClassClass 2

Intended Use

The option intended to provide the operator with the capabilities of selecting Rhodium filtration for enhanced image quality.

Device Story

Rhodium filtration option for Mamex Mammographic X-Ray system; provides operator-selectable filtration to improve image quality. Used in clinical mammography settings by radiology technicians or physicians. Device modifies X-ray beam spectrum via Rhodium filter insertion; enhances contrast/image quality for breast tissue imaging. Output is an X-ray image with optimized spectral characteristics. Benefits include improved diagnostic visualization of breast structures.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Rhodium filter material; integrated into Mamex Mammographic X-Ray system; mechanical filter selection mechanism; operates within existing X-ray generation hardware; no software or electronic components described.

Indications for Use

Indicated for use as an optional filtration component for the Mamex Mammographic X-Ray system to enhance image quality during mammographic examinations.

Regulatory Classification

Identification

A mammographic x-ray system is a device intended to be used to produce radiographs of the breast. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/0/Picture/1 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo is circular in shape, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter of the circle. Inside the circle is a stylized image of an eagle, with its wings spread and its head turned to the left. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUL 30 1999 Jeffrey N. Moeller, R.T. Director, Quality & Regulatory Affairs Gendex-Del Medical Imaging Corporation 11550 West King Street Franklin Park, Illinois 60131 RE: K992037 Mamex (Rhodium Filter) Dated: June 14, 1999 Received: June 16, 1999 Regulatory Class: II 21 CFR 892.1710/Procode: 90 IZH Dear Mr. Moeller: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class III (Special Controls) or dass III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to beging your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled. "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, CART David J.O. Stalker, M.D. CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat. and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {1}------------------------------------------------ 510(k) Number: K 992037 Device Name: Rhodium filtration option for use with "Mamex" Mammographic X- Ray system. Indications For Use: The option intended to provide the operator with the capabilities of selecting Rhodium filtration for enhanced image quality. David h. Symm (Division Sign-Off) (Division Sign-On) Division of Reproductive, Abdominal, ENT, and Radiological Devi 510(k) Number. **Prescription Use** (Per 21 CFR 801.109)
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%